|
Market Cap | 85.49M | EPS (ttm) | -1.30 |
P/E | - | EPS this Y | 14.58% |
Forward P/E | - | EPS next Y | 5.37% |
PEG | - | EPS past 5Y | 30.25% |
P/S | 101.77 | EPS next 5Y | - |
P/B | 5.53 | EPS Q/Q | -14.85% |
Dividend | - | Sales Q/Q | -90.96% |
Insider Own | 7.93% | Inst Own | 38.96% |
Insider Trans | -0.86% | Inst Trans | -3.74% |
Short Float | 15.12% | Earnings | May 09/a |
Analyst Recom | 1.00 | Target Price | 3.83 |
Avg Volume | 2.97M | 52W Range | 0.67 - 3.33 |
|
|
|
Gritstone bio, Inc. clinical-stage biotechnology company, which engages in developing the next generation of cancer immunotherapies to fight multiple cancer types. The company was founded by Andrew Allen, Timothy Chan, Mark Cobbold, Graham Lord, Naiyer Rizvi and Jean-Charles Soria in August 2015 and is headquartered in Emeryville, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Allen Andrew R | PRESIDENT AND CEO | May 16 '24 | Sale | 0.75 | 24,263 | 18,156 | 985,360 | May 17 09:58 PM | Jones Erin | EVP, CHIEF OPERATING OFFICER | May 16 '24 | Sale | 0.75 | 13,749 | 10,288 | 359,293 | May 17 09:57 PM | Jooss Karin | SEE REMARKS | May 16 '24 | Sale | 0.75 | 13,749 | 10,288 | 683,526 | May 17 09:57 PM | Economides Vassiliki | EVP, CHIEF FINANCIAL OFFICER | May 16 '24 | Sale | 0.75 | 13,749 | 10,288 | 262,437 | May 17 09:55 PM | Hawryluk Matthew | EVP, CHIEF BUSINESS OFFICER | May 16 '24 | Sale | 0.75 | 9,259 | 6,929 | 313,931 | May 17 09:56 PM |
|
|
|
|
Market Cap | 137.22B | EPS (ttm) | 0.64 |
P/E | 102.50 | EPS this Y | 5.00% |
Forward P/E | 31.31 | EPS next Y | 129.62% |
PEG | 2.18 | EPS past 5Y | - |
P/S | 3.56 | EPS next 5Y | 47.00% |
P/B | 12.39 | EPS Q/Q | -302.82% |
Dividend | - | Sales Q/Q | 14.82% |
Insider Own | 3.93% | Inst Own | 78.94% |
Insider Trans | -0.67% | Inst Trans | 1.20% |
Short Float | 2.54% | Earnings | May 08/b |
Analyst Recom | 1.29 | Target Price | 86.80 |
Avg Volume | 18.32M | 52W Range | 37.07 - 82.14 |
|
|
|
Uber Technologies, Inc. is a technology platform, which engages in the development and operation of technology applications, network, and product to power movement from point A to point B. The firm offers ride services and merchants delivery service providers for meal preparation, grocery and other delivery services. It operates through the following segments: Mobility, Delivery, and Freight. The Mobility segment refers to products that connect consumers with Mobility Drivers who provide rides in a variety of vehicles, such as cars, auto rickshaws, motorbikes, minibuses, or taxis. The Delivery segment offers consumers to search for and discover local restaurants, order a meal, and either pick-up at the restaurant or have the meal delivered and, in certain markets, Delivery also includes offerings for grocery, alcohol and convenience store delivery and other goods. The Freight segment leverages proprietary technology, brand awareness, and experience revolutionizing industries to connect carriers with shippers on Uber's platform, and gives carriers upfront, transparent pricing and the ability to book a shipment. The company was founded by Oscar Salazar Gaitan, Travis Kalanick and Garrett Camp in 2009 and is headquartered in San Francisco, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
KHOSROWSHAHI DARA | Chief Executive Officer | May 17 '24 | Option Exercise | 33.65 | 1,000,000 | 33,650,000 | 2,156,996 | May 17 09:46 PM | KHOSROWSHAHI DARA | Chief Executive Officer | May 17 '24 | Sale | 65.93 | 500,000 | 32,964,000 | 1,656,996 | May 17 09:46 PM | West Tony | See Remarks | May 13 '24 | Sale | 65.63 | 18,750 | 1,230,597 | 206,338 | May 15 05:17 PM | Hazelbaker Jill | See Remarks | Feb 14 '24 | Sale | 77.83 | 20,000 | 1,556,674 | 107,290 | Feb 16 06:58 PM | West Tony | See Remarks | Feb 12 '24 | Sale | 70.08 | 18,750 | 1,313,926 | 185,566 | Feb 14 07:31 PM |
|
|
|
|
Market Cap | 13.07B | EPS (ttm) | -3.13 |
P/E | - | EPS this Y | 34.83% |
Forward P/E | - | EPS next Y | 51.46% |
PEG | - | EPS past 5Y | -11.28% |
P/S | 10.82 | EPS next 5Y | - |
P/B | 16.39 | EPS Q/Q | 54.33% |
Dividend | - | Sales Q/Q | 52.11% |
Insider Own | 6.39% | Inst Own | 95.04% |
Insider Trans | -15.76% | Inst Trans | 1.75% |
Short Float | 5.35% | Earnings | May 09/a |
Analyst Recom | 1.50 | Target Price | 121.11 |
Avg Volume | 1.45M | 52W Range | 36.90 - 108.67 |
|
|
|
Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT). The company was founded by Matthew Rabinowitz and Jonathan Sheena in November 2003 and is headquartered in Austin, TX. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Chapman Steven Leonard | CEO AND PRESIDENT | May 15 '24 | Sale | 107.08 | 6,779 | 725,911 | 219,456 | May 17 09:35 PM | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | May 10 '24 | Option Exercise | 19.68 | 30,000 | 590,400 | 234,495 | May 10 09:35 PM | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | May 10 '24 | Sale | 104.59 | 30,000 | 3,137,567 | 204,495 | May 10 09:35 PM | Sheena Jonathan | CO-FOUNDER | May 10 '24 | Sale | 105.11 | 2,700 | 283,794 | 319,061 | May 10 09:35 PM | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | May 08 '24 | Option Exercise | 5.40 | 215,000 | 1,159,990 | 1,290,648 | May 10 09:35 PM |
|
|
| |
|
Market Cap | 1.46B | EPS (ttm) | 2.58 |
P/E | 13.89 | EPS this Y | 32.39% |
Forward P/E | 9.31 | EPS next Y | 26.11% |
PEG | - | EPS past 5Y | 208.72% |
P/S | 1.76 | EPS next 5Y | - |
P/B | 4.59 | EPS Q/Q | 69.63% |
Dividend | - | Sales Q/Q | 96.47% |
Insider Own | 55.11% | Inst Own | 15.26% |
Insider Trans | -9.08% | Inst Trans | 324.24% |
Short Float | 17.34% | Earnings | May 09/b |
Analyst Recom | 1.00 | Target Price | 44.00 |
Avg Volume | 3.07M | 52W Range | 5.25 - 45.18 |
|
|
May-18-24 09:00AM
|
7 Great Growth Stocks You Need to Own Before 2025
(InvestorPlace) |
May-17-24 03:10AM
|
GigaCloud Technology Insider Sold Shares Worth $8,642,163, According to a Recent SEC Filing
(MT Newswires) |
May-16-24 03:06AM
|
GigaCloud Technology Insider Sold Shares Worth $1,033,917, According to a Recent SEC Filing
(MT Newswires) |
May-15-24 08:00AM
|
3 Stocks That Can Turn $1,000 into $10,000 Faster Than You Think
(InvestorPlace) -5.71% |
03:10AM
|
GigaCloud Technology Insider Sold Shares Worth $12,700,553, According to a Recent SEC Filing
(MT Newswires) |
May-14-24 09:00AM
|
GigaCloud Technology Inc. (GCT) Is a Trending Stock: Facts to Know Before Betting on It
(Zacks) |
03:21AM
|
GigaCloud Technology Insider Sold Shares Worth $9,029,704, According to a Recent SEC Filing
(MT Newswires) |
May-13-24 06:00AM
|
Triple Your Money: 3 Stocks with Potential for a 300% Increase by 2025
(InvestorPlace) |
May-12-24 08:56AM
|
3 Game-Changing Stocks to Unlock Life-Changing Wealth
(InvestorPlace) |
May-11-24 05:09AM
|
Is Gigacloud Stock an Excellent Investment?
(Motley Fool) |
|
GigaCloud Technology, Inc. specializes in global end-to-end business-to-business (B2B) electronic commerce (e-commerce) for large parcel merchandise. The firm's B2B ecommerce platform, which it refers to as the GigaCloud Marketplace, integrates everything from product discovery, payments, and messaging portals, leveraging channel diversification for suppliers, while resellers gain access to thousands of products backed by a complete logistics package. Its global marketplace seamlessly connects manufacturers, primarily in Asia, with resellers, primarily in the U.S., Asia, and Europe, to execute cross-border transactions with confidence, speed, and efficiency. The firm offers a comprehensive solution that transports products from the manufacturer's warehouse to the end customer's doorstep, all in one place. The company was founded by Lei Wu on August 29, 2006 and is headquartered in El Monte, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Wu Lei | Chief Executive Officer | May 16 '24 | Sale | 36.06 | 14,188 | 511,680 | 114,190 | May 17 09:25 PM | Lin Frank Hurst | Director | May 15 '24 | Sale | 36.82 | 141,938 | 5,225,621 | 5,435,065 | May 16 09:00 PM | Wu Lei | Chief Executive Officer | May 15 '24 | Sale | 35.41 | 14,188 | 502,364 | 128,378 | May 17 09:25 PM | Lin Frank Hurst | Director | May 14 '24 | Sale | 36.78 | 92,886 | 3,416,542 | 5,577,003 | May 16 09:00 PM | Hao Xinyan | Chief Operating Officer | May 14 '24 | Sale | 37.07 | 67,455 | 2,500,732 | 787,486 | May 14 09:52 PM |
|
|
|
|
Market Cap | 105.05M | EPS (ttm) | -1.34 |
P/E | - | EPS this Y | -11.39% |
Forward P/E | - | EPS next Y | 65.34% |
PEG | - | EPS past 5Y | -22.07% |
P/S | 0.08 | EPS next 5Y | 10.00% |
P/B | - | EPS Q/Q | 68.70% |
Dividend | - | Sales Q/Q | 6.53% |
Insider Own | 4.27% | Inst Own | 72.66% |
Insider Trans | -32.47% | Inst Trans | -13.33% |
Short Float | 22.32% | Earnings | Feb 28/a |
Analyst Recom | 1.80 | Target Price | 15.25 |
Avg Volume | 417.41K | 52W Range | 5.56 - 16.50 |
|
|
|
Red Robin Gourmet Burgers, Inc. develops, operates, and franchises full-service restaurants North America. It serves a variety of salads, soups, appetizers, other entrees, desserts, signature alcoholic and non-alcoholic beverages. The company was founded in September 1969 and is headquartered in Englewood, CO. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Archon Capital Management LLC | 10% Owner | May 17 '24 | Sale | 6.85 | 100,200 | 686,495 | 1,551,587 | May 17 09:15 PM | Archon Capital Management LLC | 10% Owner | May 16 '24 | Sale | 7.09 | 141,905 | 1,005,794 | 1,651,787 | May 17 09:15 PM | Archon Capital Management LLC | 10% Owner | May 15 '24 | Sale | 7.36 | 77,000 | 566,512 | 1,793,692 | May 17 09:15 PM | Archon Capital Management LLC | 10% Owner | Oct 04 '23 | Buy | 7.57 | 6,000 | 45,420 | 1,870,692 | Oct 05 04:47 PM | Archon Capital Management LLC | 10% Owner | Oct 03 '23 | Buy | 7.43 | 50,000 | 371,500 | 1,864,692 | Oct 05 04:47 PM |
|
|
| |
|
Market Cap | 3.27B | EPS (ttm) | -0.24 |
P/E | - | EPS this Y | 12.30% |
Forward P/E | 17.53 | EPS next Y | 22.10% |
PEG | - | EPS past 5Y | 19.55% |
P/S | 4.52 | EPS next 5Y | 13.40% |
P/B | 2.53 | EPS Q/Q | -61.25% |
Dividend | - | Sales Q/Q | 16.00% |
Insider Own | 66.21% | Inst Own | 41.50% |
Insider Trans | -0.55% | Inst Trans | -0.60% |
Short Float | 14.48% | Earnings | May 07/a |
Analyst Recom | 1.36 | Target Price | 25.26 |
Avg Volume | 1.05M | 52W Range | 16.15 - 25.16 |
|
|
|
PowerSchool Holdings, Inc. operates as a holding company, which offers cloud-based software to the K-12 education market. It provides a unified platform that includes the core system of record used by districts and schools and leverages rich data to deliver insights and analytics to improve education outcomes. The company was founded in 1997 and is headquartered in Folsom, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
GULATI HARDEEP | Chief Executive Officer | May 17 '24 | Sale | 19.37 | 20,434 | 395,807 | 1,855,667 | May 17 09:15 PM | GULATI HARDEEP | Chief Executive Officer | May 16 '24 | Sale | 19.09 | 25,766 | 491,873 | 1,876,101 | May 17 09:15 PM | GULATI HARDEEP | Chief Executive Officer | May 15 '24 | Sale | 19.01 | 3,800 | 72,238 | 1,901,867 | May 17 09:15 PM | GULATI HARDEEP | Chief Executive Officer | Apr 08 '24 | Sale | 21.33 | 6,171 | 131,627 | 1,905,667 | Apr 29 04:33 PM | GULATI HARDEEP | Chief Executive Officer | Apr 05 '24 | Sale | 21.06 | 21,900 | 461,214 | 1,911,838 | Apr 05 05:04 PM |
|
|
|
|
Market Cap | 2.25B | EPS (ttm) | -3.97 |
P/E | - | EPS this Y | 21.41% |
Forward P/E | - | EPS next Y | -7.06% |
PEG | - | EPS past 5Y | -106.26% |
P/S | - | EPS next 5Y | - |
P/B | 5.04 | EPS Q/Q | -3.25% |
Dividend | - | Sales Q/Q | - |
Insider Own | 34.22% | Inst Own | 82.59% |
Insider Trans | -10.69% | Inst Trans | -3.15% |
Short Float | 18.04% | Earnings | May 02/a |
Analyst Recom | 1.00 | Target Price | 39.22 |
Avg Volume | 1.24M | 52W Range | 6.40 - 30.27 |
|
|
|
Dyne Therapeutics, Inc. engages in developing innovative life-transforming therapies for genetically driven muscle diseases. It develops a broad portfolio of therapeutics for muscle diseases, including lead programs in myotonic dystrophy type 1, Duchenne muscular dystrophy, and facioscapulohumeral muscular dystroph. The company was founded by Jason P. Rhodes and Romesh R. Subramanian on December 1, 2017 and is headquartered in Waltham, MA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
McNeill Jonathan | Chief Business Officer | May 16 '24 | Sale | 28.27 | 2,774 | 78,420 | 136,634 | May 17 09:03 PM | HIGH SUSANNA GATTI | Chief Operating Officer | May 16 '24 | Sale | 28.27 | 2,738 | 77,402 | 154,062 | May 17 09:05 PM | Beskrovnaya Oxana | Chief Scientific Officer | May 16 '24 | Sale | 28.27 | 2,705 | 76,469 | 149,647 | May 17 09:07 PM | Scalzo Richard William | SVP, Head of Finance & Admin. | May 16 '24 | Sale | 28.27 | 2,588 | 73,162 | 116,695 | May 17 09:04 PM | Farwell Wildon | Chief Medical Officer | May 16 '24 | Sale | 28.27 | 2,381 | 67,310 | 148,179 | May 17 09:06 PM |
|
|
| |
|
Market Cap | 2.37B | EPS (ttm) | 7.27 |
P/E | 19.15 | EPS this Y | 30.19% |
Forward P/E | 16.04 | EPS next Y | 7.42% |
PEG | 2.39 | EPS past 5Y | - |
P/S | 1.62 | EPS next 5Y | 8.00% |
P/B | 2.92 | EPS Q/Q | 53.94% |
Dividend | - | Sales Q/Q | 33.85% |
Insider Own | 7.16% | Inst Own | 90.98% |
Insider Trans | -8.66% | Inst Trans | -2.23% |
Short Float | 1.91% | Earnings | Apr 25/b |
Analyst Recom | 1.00 | Target Price | 166.00 |
Avg Volume | 93.16K | 52W Range | 103.04 - 144.11 |
|
|
May-15-24 08:50AM
|
OSI (OSIS) Is a Great Choice for 'Trend' Investors, Here's Why
(Zacks) |
May-13-24 08:30AM
|
OSI Systems Receives Order for $9 Million to Provide Cargo and Vehicle Inspection Systems
(Business Wire) |
May-10-24 03:54AM
|
OSI Systems Insider Sold Shares Worth $1,340,875, According to a Recent SEC Filing
(MT Newswires) |
02:40AM
|
Insider Sale: Director James Hawkins Sells Shares of OSI Systems Inc (OSIS)
(GuruFocus.com) |
May-07-24 08:30AM
|
OSI Systems Receives $6 Million Order for Electronic Assemblies
(Business Wire) |
May-03-24 05:00PM
|
OSI Systems President and CEO Deepak Chopra to Retire by Calendar Year-End, Will Remain as Executive Chairman
(Business Wire) |
04:01PM
|
OSI Systems to Present at Oppenheimer 19th Annual Industrial Growth Conference
(Business Wire) |
May-01-24 05:37PM
|
Osi Systems Insider Sold Shares Worth $1,561,387, According to a Recent SEC Filing
(MT Newswires) |
Apr-30-24 10:57AM
|
OSI Systems, Inc. (NASDAQ:OSIS) Q3 2024 Earnings Call Transcript
(Insider Monkey) |
Apr-29-24 08:43AM
|
Oppenheimer Adjusts OSI Systems Price Target to $160 From $157, Maintains Outperform Rating
(MT Newswires) |
|
OSI Systems, Inc. engages in the design and manufacture of specialized electronic systems, and components for critical applications. It operates through the following segments: Security, Healthcare, and Optoelectronics and Manufacturing. The Security segment includes security inspection systems and related services, and turnkey security screening solutions. The Healthcare segment provides patient monitoring, diagnostic cardiology, and related services. The Optoelectronics and Manufacturing segment refers to electronic components and electronic manufacturing services. The company was founded by Deepak Chopra in May 1987 and is headquartered in Hawthorne, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
CHOPRA DEEPAK | PRESIDENT AND CEO | May 15 '24 | Sale | 139.75 | 40,000 | 5,589,823 | 428,615 | May 17 09:00 PM | HAWKINS JAMES B | Director | May 08 '24 | Sale | 134.09 | 10,000 | 1,340,875 | 7,834 | May 09 06:16 PM | CHIZEVER GERALD M | Director | May 08 '24 | Sale | 134.11 | 3,000 | 402,330 | 10,515 | May 09 06:26 PM | Ballhaus William Francis JR | Director | May 08 '24 | Sale | 133.98 | 675 | 90,436 | 25,907 | May 09 06:29 PM | LUSKIN MEYER/ | Director | Apr 30 '24 | Sale | 130.76 | 5,000 | 653,800 | 15,883 | May 01 05:30 PM |
|
|
|
|
Market Cap | 59.25M | EPS (ttm) | -0.43 |
P/E | - | EPS this Y | -22.73% |
Forward P/E | - | EPS next Y | 13.89% |
PEG | - | EPS past 5Y | 62.58% |
P/S | 1.22 | EPS next 5Y | - |
P/B | 3.32 | EPS Q/Q | 12.31% |
Dividend | - | Sales Q/Q | 39.91% |
Insider Own | 10.23% | Inst Own | 81.23% |
Insider Trans | 26.69% | Inst Trans | 0.68% |
Short Float | 3.84% | Earnings | May 13/a |
Analyst Recom | 1.67 | Target Price | 4.98 |
Avg Volume | 625.11K | 52W Range | 0.99 - 6.25 |
|
|
|
Augmedix, Inc. engages in the development of software that converts natural clinician-patient conversations into medical documentation. It offers live support including referrals, orders, and reminders that allow clinicians to focus on patient care. The company was founded by Ian Shakil in 2012 and is headquartered in San Francisco, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Krakaris Emmanuel | PRESIDENT, CEO, AND SECRETARY | May 15 '24 | Sale | 1.19 | 3,528 | 4,198 | 58,898 | May 17 09:00 PM | Ginocchio Paul | CHIEF FINANCIAL OFFICER | May 15 '24 | Sale | 1.19 | 2,354 | 2,801 | 131,896 | May 17 09:00 PM | Breber Sandra | CHIEF OPERATING OFFICER | May 15 '24 | Sale | 1.19 | 2,354 | 2,801 | 16,396 | May 17 09:00 PM | Chatterjee Saurav | CHIEF TECHNOLOGY OFFICER | May 15 '24 | Sale | 1.19 | 1,767 | 2,103 | 2,921 | May 17 09:00 PM | Hawkins Jonathan | CHIEF REVENUE OFFICER | May 15 '24 | Sale | 1.19 | 1,767 | 2,103 | 2,921 | May 17 09:00 PM |
|
|
|
|
Market Cap | 426.65M | EPS (ttm) | -3.25 |
P/E | - | EPS this Y | 10.60% |
Forward P/E | - | EPS next Y | 3.17% |
PEG | - | EPS past 5Y | -172.30% |
P/S | - | EPS next 5Y | - |
P/B | 2.38 | EPS Q/Q | 8.44% |
Dividend | - | Sales Q/Q | - |
Insider Own | 16.15% | Inst Own | 70.02% |
Insider Trans | 94.89% | Inst Trans | -0.43% |
Short Float | 1.66% | Earnings | May 14/a |
Analyst Recom | 1.00 | Target Price | 21.60 |
Avg Volume | 83.36K | 52W Range | 3.72 - 17.51 |
|
|
|
PepGen Inc. develops oligonucleotide therapies. It is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases. The company was founded in March 26, 2018 and is headquartered in Boston, MA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Svenstrup Niels | SVP, Chem. Mfg & Controls | May 17 '24 | Sale | 13.41 | 10,000 | 134,100 | 0 | May 17 08:51 PM | RA CAPITAL MANAGEMENT, L.P. | Director | Feb 09 '24 | Buy | 10.64 | 2,557,593 | 27,212,790 | 9,179,273 | Feb 13 04:33 PM | McArthur James G | President and CEO | Nov 30 '23 | Buy | 4.17 | 1,694 | 7,056 | 1,694 | Dec 05 07:34 AM | McArthur James G | President and CEO | Jun 08 '23 | Option Exercise | 2.71 | 2,381 | 6,453 | 2,381 | Jun 09 07:06 PM | McArthur James G | President and CEO | Jun 08 '23 | Sale | 16.04 | 2,381 | 38,188 | 0 | Jun 09 07:06 PM |
|
|
|